Natural biomaterials are any material taken from plants or animals and used to augment, replace, or repair body tissues and organs.
The global Natural Biomaterials market is projected to grow from US$ 62140 million in 2023 to US$ 99710 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
The US & Canada market for Natural Biomaterials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Natural Biomaterials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Natural Biomaterials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Natural Biomaterials include BASF, Biomet, Invibio, Mimetis Biomaterials, Royal DSM, Corbion, Botiss Biomaterials and Medtronic, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Natural Biomaterials production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Natural Biomaterials by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Natural Biomaterials, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Natural Biomaterials, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Natural Biomaterials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Natural Biomaterials sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Natural Biomaterials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Natural Biomaterials sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Biomet, Invibio, Mimetis Biomaterials, Royal DSM, Corbion, Botiss Biomaterials and Medtronic, etc.
By Company
BASF
Biomet
Invibio
Mimetis Biomaterials
Royal DSM
Corbion
Botiss Biomaterials
Medtronic
Segment by Type
Collagen
Hyaluronic Acid
Gelatin
Heparin
Fibrin
Cellulose
Chitosan
Others
Segment by Application
Regenerative Medicine
Gene Therapy
Immunotherapy
Stem-Cell Therapy
Tissue Engineering
Other
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Natural Biomaterials production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Natural Biomaterials in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Natural Biomaterials manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Biomaterials sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Natural Biomaterials Product Introduction
1.2 Market by Type
1.2.1 Global Natural Biomaterials Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Collagen
1.2.3 Hyaluronic Acid
1.2.4 Gelatin
1.2.5 Heparin
1.2.6 Fibrin
1.2.7 Cellulose
1.2.8 Chitosan
1.2.9 Others
1.3 Market by Application
1.3.1 Global Natural Biomaterials Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Regenerative Medicine
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Stem-Cell Therapy
1.3.6 Tissue Engineering
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Natural Biomaterials Production
2.1 Global Natural Biomaterials Production Capacity (2018-2029)
2.2 Global Natural Biomaterials Production by Region: 2018 VS 2022 VS 2029
2.3 Global Natural Biomaterials Production by Region
2.3.1 Global Natural Biomaterials Historic Production by Region (2018-2023)
2.3.2 Global Natural Biomaterials Forecasted Production by Region (2024-2029)
2.3.3 Global Natural Biomaterials Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Natural Biomaterials Revenue Estimates and Forecasts 2018-2029
3.2 Global Natural Biomaterials Revenue by Region
3.2.1 Global Natural Biomaterials Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Natural Biomaterials Revenue by Region (2018-2023)
3.2.3 Global Natural Biomaterials Revenue by Region (2024-2029)
3.2.4 Global Natural Biomaterials Revenue Market Share by Region (2018-2029)
3.3 Global Natural Biomaterials Sales Estimates and Forecasts 2018-2029
3.4 Global Natural Biomaterials Sales by Region
3.4.1 Global Natural Biomaterials Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Natural Biomaterials Sales by Region (2018-2023)
3.4.3 Global Natural Biomaterials Sales by Region (2024-2029)
3.4.4 Global Natural Biomaterials Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Natural Biomaterials Sales by Manufacturers
4.1.1 Global Natural Biomaterials Sales by Manufacturers (2018-2023)
4.1.2 Global Natural Biomaterials Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Natural Biomaterials in 2022
4.2 Global Natural Biomaterials Revenue by Manufacturers
4.2.1 Global Natural Biomaterials Revenue by Manufacturers (2018-2023)
4.2.2 Global Natural Biomaterials Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Natural Biomaterials Revenue in 2022
4.3 Global Natural Biomaterials Sales Price by Manufacturers
4.4 Global Key Players of Natural Biomaterials, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Natural Biomaterials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Natural Biomaterials, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Natural Biomaterials, Product Offered and Application
4.8 Global Key Manufacturers of Natural Biomaterials, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Natural Biomaterials Sales by Type
5.1.1 Global Natural Biomaterials Historical Sales by Type (2018-2023)
5.1.2 Global Natural Biomaterials Forecasted Sales by Type (2024-2029)
5.1.3 Global Natural Biomaterials Sales Market Share by Type (2018-2029)
5.2 Global Natural Biomaterials Revenue by Type
5.2.1 Global Natural Biomaterials Historical Revenue by Type (2018-2023)
5.2.2 Global Natural Biomaterials Forecasted Revenue by Type (2024-2029)
5.2.3 Global Natural Biomaterials Revenue Market Share by Type (2018-2029)
5.3 Global Natural Biomaterials Price by Type
5.3.1 Global Natural Biomaterials Price by Type (2018-2023)
5.3.2 Global Natural Biomaterials Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Natural Biomaterials Sales by Application
6.1.1 Global Natural Biomaterials Historical Sales by Application (2018-2023)
6.1.2 Global Natural Biomaterials Forecasted Sales by Application (2024-2029)
6.1.3 Global Natural Biomaterials Sales Market Share by Application (2018-2029)
6.2 Global Natural Biomaterials Revenue by Application
6.2.1 Global Natural Biomaterials Historical Revenue by Application (2018-2023)
6.2.2 Global Natural Biomaterials Forecasted Revenue by Application (2024-2029)
6.2.3 Global Natural Biomaterials Revenue Market Share by Application (2018-2029)
6.3 Global Natural Biomaterials Price by Application
6.3.1 Global Natural Biomaterials Price by Application (2018-2023)
6.3.2 Global Natural Biomaterials Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Natural Biomaterials Market Size by Type
7.1.1 US & Canada Natural Biomaterials Sales by Type (2018-2029)
7.1.2 US & Canada Natural Biomaterials Revenue by Type (2018-2029)
7.2 US & Canada Natural Biomaterials Market Size by Application
7.2.1 US & Canada Natural Biomaterials Sales by Application (2018-2029)
7.2.2 US & Canada Natural Biomaterials Revenue by Application (2018-2029)
7.3 US & Canada Natural Biomaterials Sales by Country
7.3.1 US & Canada Natural Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Natural Biomaterials Sales by Country (2018-2029)
7.3.3 US & Canada Natural Biomaterials Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Natural Biomaterials Market Size by Type
8.1.1 Europe Natural Biomaterials Sales by Type (2018-2029)
8.1.2 Europe Natural Biomaterials Revenue by Type (2018-2029)
8.2 Europe Natural Biomaterials Market Size by Application
8.2.1 Europe Natural Biomaterials Sales by Application (2018-2029)
8.2.2 Europe Natural Biomaterials Revenue by Application (2018-2029)
8.3 Europe Natural Biomaterials Sales by Country
8.3.1 Europe Natural Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Natural Biomaterials Sales by Country (2018-2029)
8.3.3 Europe Natural Biomaterials Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Natural Biomaterials Market Size by Type
9.1.1 China Natural Biomaterials Sales by Type (2018-2029)
9.1.2 China Natural Biomaterials Revenue by Type (2018-2029)
9.2 China Natural Biomaterials Market Size by Application
9.2.1 China Natural Biomaterials Sales by Application (2018-2029)
9.2.2 China Natural Biomaterials Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Natural Biomaterials Market Size by Type
10.1.1 Asia Natural Biomaterials Sales by Type (2018-2029)
10.1.2 Asia Natural Biomaterials Revenue by Type (2018-2029)
10.2 Asia Natural Biomaterials Market Size by Application
10.2.1 Asia Natural Biomaterials Sales by Application (2018-2029)
10.2.2 Asia Natural Biomaterials Revenue by Application (2018-2029)
10.3 Asia Natural Biomaterials Sales by Region
10.3.1 Asia Natural Biomaterials Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Natural Biomaterials Revenue by Region (2018-2029)
10.3.3 Asia Natural Biomaterials Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Natural Biomaterials Market Size by Type
11.1.1 Middle East, Africa and Latin America Natural Biomaterials Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Natural Biomaterials Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Natural Biomaterials Market Size by Application
11.2.1 Middle East, Africa and Latin America Natural Biomaterials Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Natural Biomaterials Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Natural Biomaterials Sales by Country
11.3.1 Middle East, Africa and Latin America Natural Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Natural Biomaterials Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Natural Biomaterials Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Overview
12.1.3 BASF Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 BASF Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 Biomet
12.2.1 Biomet Company Information
12.2.2 Biomet Overview
12.2.3 Biomet Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Biomet Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Biomet Recent Developments
12.3 Invibio
12.3.1 Invibio Company Information
12.3.2 Invibio Overview
12.3.3 Invibio Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Invibio Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Invibio Recent Developments
12.4 Mimetis Biomaterials
12.4.1 Mimetis Biomaterials Company Information
12.4.2 Mimetis Biomaterials Overview
12.4.3 Mimetis Biomaterials Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Mimetis Biomaterials Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Mimetis Biomaterials Recent Developments
12.5 Royal DSM
12.5.1 Royal DSM Company Information
12.5.2 Royal DSM Overview
12.5.3 Royal DSM Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Royal DSM Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Royal DSM Recent Developments
12.6 Corbion
12.6.1 Corbion Company Information
12.6.2 Corbion Overview
12.6.3 Corbion Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Corbion Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Corbion Recent Developments
12.7 Botiss Biomaterials
12.7.1 Botiss Biomaterials Company Information
12.7.2 Botiss Biomaterials Overview
12.7.3 Botiss Biomaterials Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Botiss Biomaterials Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Botiss Biomaterials Recent Developments
12.8 Medtronic
12.8.1 Medtronic Company Information
12.8.2 Medtronic Overview
12.8.3 Medtronic Natural Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Medtronic Natural Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Medtronic Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Natural Biomaterials Industry Chain Analysis
13.2 Natural Biomaterials Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Natural Biomaterials Production Mode & Process
13.4 Natural Biomaterials Sales and Marketing
13.4.1 Natural Biomaterials Sales Channels
13.4.2 Natural Biomaterials Distributors
13.5 Natural Biomaterials Customers
14 Natural Biomaterials Market Dynamics
14.1 Natural Biomaterials Industry Trends
14.2 Natural Biomaterials Market Drivers
14.3 Natural Biomaterials Market Challenges
14.4 Natural Biomaterials Market Restraints
15 Key Finding in The Global Natural Biomaterials Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
BASF
Biomet
Invibio
Mimetis Biomaterials
Royal DSM
Corbion
Botiss Biomaterials
Medtronic
*If Applicable.